Tech Company Financing Transactions
Xeltis Funding Round
Xeltis, based in Eindhoven, raised $15.4 million in investment from Grand Pharmaceutical Group.
Transaction Overview
Company Name
Announced On
8/10/2022
Transaction Type
Venture Equity
Amount
$15,400,000
Round
Series D
Investors
Grand Pharmaceutical Group (Lead Investor) (Frank Zhou)
Proceeds Purpose
The deal will focus on the restorative hemodialysis access device from Xeltis called aXess and allow the startup to roll out additional novel hemodialysis products.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
De Lismortel 31
Eindhoven, 5612AR
The Netherlands
Eindhoven, 5612AR
The Netherlands
Phone
Website
Email Address
Overview
Xeltis is a clinical-stage medical device company with the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis' devices naturally evolve into living blood vessels or heart valves, when colonized by patient's own tissue.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eliane Schutte
Chief Financial Officer
Alexander Goemans
Chief Technical Officer
Martijn Cox
Vice President
Paulo Neves
Browse more venture capital transactions:
Prev: 8/10/2022: Prellis Biologics venture capital transaction
Next: 8/11/2022: Risc Zero venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs